Mail

UK markets close in 1 hour 14 minutes

FTSE 100
8,227.23
+55.08(+0.67%)
FTSE 250
20,231.38
+179.05(+0.89%)
AIM
771.89
+3.78(+0.49%)
GBP/EUR
1.1655
-0.0028(-0.24%)
GBP/USD
1.2545
+0.0012(+0.10%)
Bitcoin GBP
49,090.86
+2,585.25(+5.56%)

11 fabulous farmhouses perfect for living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

Agile Therapeutics, Inc. (AGRX)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.4050

+0.0002

(+0.05%)

As of 09:29AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	2.78M
Enterprise value	2.39M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.04
Price/book (mrq)	1.78
Enterprise value/revenue	0.12
Enterprise value/EBITDA	-0.19

Trading information

Stock price history

Beta (5Y monthly)	1.40
52-week change ³	-93.14%
S&P500 52-week change ³	22.43%
52-week high ³	6.7140
52-week low ³	0.2000
50-day moving average ³	0.5282
200-day moving average ³	1.6302

Share statistics

Avg vol (3-month) ³	730.76k
Avg vol (10-day) ³	49.1k
Shares outstanding ⁵	6.86M
Implied shares outstanding ⁶	6.86M
Float ⁸	6.85M
% held by insiders ¹	0.23%
% held by institutions ¹	3.90%
Shares short (29 Feb 2024) ⁴	222.1k
Short ratio (29 Feb 2024) ⁴	0.28
Short % of float (29 Feb 2024) ⁴	7.50%
Short % of shares outstanding (29 Feb 2024) ⁴	7.49%
Shares short (prior month 31 Jan 2024) ⁴	189.89k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:50
Last split date ³	11 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-73.83%
Operating margin (ttm)	-112.12%

Management effectiveness

Return on assets (ttm)	-101.46%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	19.59M
Revenue per share (ttm)	9.09
Quarterly revenue growth (yoy)	-9.60%
Gross profit (ttm)	N/A
EBITDA	-19.5M
Net income avi to common (ttm)	-14.46M
Diluted EPS (ttm)	-6.7100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	2.56M
Total cash per share (mrq)	0.37
Total debt (mrq)	2.17M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.46
Book value per share (mrq)	-5.51

Cash flow statement

Operating cash flow (ttm)	-9.58M
Levered free cash flow (ttm)	-3.68M